|
|
|
|
|
|
by hyperpallium2
1940 days ago
|
|
|
Years ago, genome sequencing was getting exponentially cheaper, and supposedly would be desktop-priced soon. Did that not happen? I noticed companies moving into the space, like 23andme, and wondered if they might work in combination to keep consumer prices high... |
|
|
23andme is not doing sequencing, they're doing genotyping. And they are doing so using relatively old and well-established method; so I highly doubt they will be a force of innovation in the sector for the coming times.